全球體液採集與診斷市場規模、佔有率、趨勢及成長分析報告（2026-2034年）

預計體液採集和診斷的市場規模將從 2025 年的 400.7 億美元成長到 2034 年的 733 億美元，2026 年至 2034 年的複合年成長率為 6.94%。

受對精準早期疾病診斷需求不斷成長的推動，全球體液採集和診斷市場正經歷強勁成長。血液、尿液、腦脊髓液和唾液等體液在檢測多種疾病方面發揮著至關重要的作用。人們對預防醫學和定期體檢的日益重視，促進了診斷檢測的普及。全球診斷實驗室和醫院的擴張也推動了市場發展。

主要促進因素包括糖尿病、癌症和心血管疾病等慢性病盛行率的上升。診斷設備和微創採樣方法的技術進步提高了患者的舒適度和檢測準確性。就地檢驗解決方案的日益普及進一步加速了市場成長。此外，新興國家政府為加強醫療基礎設施所做的努力也有助於提高診斷服務的可近性。

由於分子診斷和自動化檢測系統的持續創新，市場前景仍然樂觀。數位健康技術和數據分析的融合有望提高診斷準確性。各公司正致力於研發速度更快、成本更低的檢測套組。隨著醫療系統日益重視早期檢測和個人化醫療，體液診斷的需求預計將持續穩定成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球體液採集與診斷市場：依樣本類型分類

• 市場分析、洞察與預測
• 血
• 唾液
• 尿
• 腦脊髓液

第5章 全球體液採集與診斷市場：依產品分類

• 市場分析、洞察與預測
• 測試和服務
• 試劑盒和耗材
• 裝置

第6章 全球體液採集與診斷市場：依技術分類

• 市場分析、洞察與預測
• 次世代定序
• 聚合酵素鏈鎖反應（PCR）
• 螢光原位雜合反應（FISH）
• 其他

第7章 全球體液採集與診斷市場：依應用領域分類

• 市場分析、洞察與預測
• 診斷和監測
• 治療方案製定
• 預後診斷和篩檢

第8章 全球體液採集與診斷市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Thermo Fisher Scientific Inc
  • Bio-Rad Laboratories
  • Illumina Inc
  • Guardant Health
  • Qiagen
  • Johnson & Johnson
  • Laboratory Corporation Of America Holdings
  • Biocept Inc
  • F. Hoffmann-La Roche Ltd
  • MDxHealth SA

The Body Fluid Collection And Diagnostics Market size is expected to reach USD 73.30 Billion in 2034 from USD 40.07 Billion (2025) growing at a CAGR of 6.94% during 2026-2034.

The Global Body Fluid Collection and Diagnostics Market is witnessing strong growth due to the increasing demand for accurate and early disease diagnosis. Body fluids such as blood, urine, cerebrospinal fluid, and saliva play a crucial role in detecting various medical conditions. Growing awareness about preventive healthcare and routine health check-ups is boosting the use of diagnostic tests. The expansion of diagnostic laboratories and hospitals worldwide is also contributing to market development.

Key drivers include the rising prevalence of chronic diseases such as diabetes, cancer, and cardiovascular disorders. Technological advancements in diagnostic equipment and minimally invasive collection methods are improving patient comfort and test accuracy. The increasing adoption of point-of-care testing solutions is further accelerating market growth. Additionally, government initiatives to strengthen healthcare infrastructure in emerging countries are expanding access to diagnostic services.

Future prospects for this market remain promising, with continuous innovation in molecular diagnostics and automated laboratory systems. The integration of digital health technologies and data analytics is expected to improve diagnostic precision. Companies are investing in the development of faster and more cost-effective testing kits. As healthcare systems emphasize early detection and personalized medicine, the demand for body fluid diagnostics will continue to grow steadily.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Sample

• Blood
• Saliva
• Urine
• Cerebrospinal Fluid

By Product

• Tests/Services
• Kits & Consumables
• Instruments

By Technology

• Next Generation Sequencing
• Polymerase Chain Reaction (PCR)
• Fluorescence in situ hybridization (FISH)
• Others

By Application

• Diagnostics & Monitoring
• Therapeutic Decision Making
• Prognostics & Screening

COMPANIES PROFILED

• Thermo Fisher Scientific Inc, BioRad Laboratories, Illumina Inc, Guardant Health, Qiagen, Johnson Johnson, Laboratory Corporation of America Holdings, Biocept Inc, F HoffmannLa Roche Ltd, MDxHealth SA
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BODY FLUID COLLECTION AND DIAGNOSTICS MARKET: BY SAMPLE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Sample
• 4.2. Blood Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Saliva Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Urine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Cerebrospinal Fluid Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BODY FLUID COLLECTION AND DIAGNOSTICS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Product
• 5.2. Tests/Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Kits & Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BODY FLUID COLLECTION AND DIAGNOSTICS MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Technology
• 6.2. Next Generation Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Polymerase Chain Reaction (PCR) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Fluorescence in situ hybridization (FISH) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BODY FLUID COLLECTION AND DIAGNOSTICS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Application
• 7.2. Diagnostics & Monitoring Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Therapeutic Decision Making Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Prognostics & Screening Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL BODY FLUID COLLECTION AND DIAGNOSTICS MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Sample
  • 8.2.2 By Product
  • 8.2.3 By Technology
  • 8.2.4 By Application
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Sample
  • 8.3.2 By Product
  • 8.3.3 By Technology
  • 8.3.4 By Application
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Sample
  • 8.4.2 By Product
  • 8.4.3 By Technology
  • 8.4.4 By Application
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Sample
  • 8.5.2 By Product
  • 8.5.3 By Technology
  • 8.5.4 By Application
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Sample
  • 8.6.2 By Product
  • 8.6.3 By Technology
  • 8.6.4 By Application
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL BODY FLUID COLLECTION AND DIAGNOSTICS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Thermo Fisher Scientific Inc
  • 10.2.2 Bio-Rad Laboratories
  • 10.2.3 Illumina Inc
  • 10.2.4 Guardant Health
  • 10.2.5 Qiagen
  • 10.2.6 Johnson & Johnson
  • 10.2.7 Laboratory Corporation Of America Holdings
  • 10.2.8 Biocept Inc
  • 10.2.9 F. Hoffmann-La Roche Ltd
  • 10.2.10 MDxHealth SA